Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.

被引：0
|
作者：
Gutierrez, K. [1 ]
Scheuermann, J. [1 ]
Goldvarg, I. [1 ]
Joshi, S. [1 ]
Tyson, G. [1 ]
Bzowej, N. [1 ]
Girgrah, N. [1 ]
Anders, S. [1 ]
Loss, G. [1 ]
Therapondos, G. [1 ]
机构：
[1] Ochsner Med Ctr, Mulitorgan Transplant Inst, New Orleans, LA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D297
引用
收藏
页码：793 / 794
页数：2
相关论文
共 50 条
  • [1] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [2] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [3] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    [J]. HEPATOLOGY, 2016, 64 : 995A - 996A
  • [4] SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE
    Selim, K.
    Elhazin, B.
    Long, W.
    Karmanova, M.
    Salazar, J.
    Volk, M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S789
  • [5] The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data
    Pyrsopoulos, Nikolaos
    Trilianos, Panagiotis
    Lingiah, Vivek A.
    Fung, Phoenix
    Punnoose, Merlin
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 761 - 765
  • [6] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    [J]. HEPATOLOGY, 2016, 64 : 810A - 810A
  • [7] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [8] Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1, Hepatitis C Infection Post Liver Transplant.
    Jones, D.
    Baggett, S.
    Shoreibah, M.
    Massoud, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 790 - 790
  • [9] Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
    Rishi Arora
    Michelle T Martin
    Justin Boike
    Sonalie Patel
    [J]. World Journal of Hepatology, 2023, (02) : 318 - 320
  • [10] Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post-Liver Transplant in a Real-World Population
    Hawkins, Kelsey L.
    Hot, Ives
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (05) : 199 - 203
12345